Insights2020-04-03T12:18:37-04:00

On-demand Webinar: A Novel Method to Improve Validity and Relevance Of Indirect Comparisons and Network Meta-Analysis

Watch PRECISIONheor’s Jeroen Jansen, and partner David Phillippo, as they provide an introduction to a novel method, called multilevel network meta-regression (ML-NMR). The method addresses several limitations with current methods, including synthesizing networks of any size and availability of IPD or aggregate studies, and – crucially for decision-making – producing estimates in any target population of interest.

LEARN MORE

Welcome: Hema Viswanathan, PhD

Precision is excited to welcome Hema Viswanathan as Vice President, PRECISIONheor. With more than 15 years experience in the industry, Hema brings exceptional insights and strategic vision. Hema will support cross functions in health economics and outcomes research (HEOR) from RWE, Evidence Synthesis and Modeling. Welcome to the Precision team!

LEARN MORE

LOAD MORE INSIGHTS

COVID-19 Pandemic Vindicates the ISPOR Value Flower

ISPOR's “value flower” versus the traditional QALYs approach: Precision's Jason Shafrin, Kathy Lang and Ross Maclean discuss why the “value flower” model can more accurately value treatments - in cases like COVID-19 - which have a transformational impact on the lives of not only of patients, but also caregivers, employers, and broader society.

LEARN MORE

LOAD MORE INSIGHTS

On-demand Webinar: A Novel Method to Improve Validity and Relevance Of Indirect Comparisons and Network Meta-Analysis

Watch PRECISIONheor’s Jeroen Jansen, and partner David Phillippo, as they provide an introduction to a novel method, called multilevel network meta-regression (ML-NMR). The method addresses several limitations with current methods, including synthesizing networks of any size and availability of IPD or aggregate studies, and – crucially for decision-making – producing estimates in any target population of interest.

LEARN MORE

LOAD MORE INSIGHTS

Welcome: Hema Viswanathan, PhD

Precision is excited to welcome Hema Viswanathan as Vice President, PRECISIONheor. With more than 15 years experience in the industry, Hema brings exceptional insights and strategic vision. Hema will support cross functions in health economics and outcomes research (HEOR) from RWE, Evidence Synthesis and Modeling. Welcome to the Precision team!

LEARN MORE

LOAD MORE INSIGHTS

On-demand Webinar: A Novel Method to Improve Validity and Relevance Of Indirect Comparisons and Network Meta-Analysis

Watch PRECISIONheor’s Jeroen Jansen, and partner David Phillippo, as they provide an introduction to a novel method, called multilevel network meta-regression (ML-NMR). The method addresses several limitations with current methods, including synthesizing networks of any size and availability of IPD or aggregate studies, and – crucially for decision-making – producing estimates in any target population of interest.

LEARN MORE

Welcome: Hema Viswanathan, PhD

Precision is excited to welcome Hema Viswanathan as Vice President, PRECISIONheor. With more than 15 years experience in the industry, Hema brings exceptional insights and strategic vision. Hema will support cross functions in health economics and outcomes research (HEOR) from RWE, Evidence Synthesis and Modeling. Welcome to the Precision team!

LEARN MORE

COVID-19 Pandemic Vindicates the ISPOR Value Flower

ISPOR's “value flower” versus the traditional QALYs approach: Precision's Jason Shafrin, Kathy Lang and Ross Maclean discuss why the “value flower” model can more accurately value treatments - in cases like COVID-19 - which have a transformational impact on the lives of not only of patients, but also caregivers, employers, and broader society.

LEARN MORE

COVID-19 Pandemic Vindicates the ISPOR Value Flower

ISPOR's “value flower” versus the traditional QALYs approach: Precision's Jason Shafrin, Kathy Lang and Ross Maclean discuss why the “value flower” model can more accurately value treatments - in cases like COVID-19 - which have a transformational impact on the lives of not only of patients, but also caregivers, employers, and broader society.

LEARN MORE

The role of COVID-19 antibody testing for employers

As employers consider including COVID-19 testing as part of their reopening plans, Precision experts Jacquelyn Chou, Caroline Huber and Jennifer Millard discuss the two key issues that must be resolved before antibody testing can be truly useful for an employer.

LEARN MORE

On-demand Webinar: A Novel Method to Improve Validity and Relevance Of Indirect Comparisons and Network Meta-Analysis

Watch PRECISIONheor’s Jeroen Jansen, and partner David Phillippo, as they provide an introduction to a novel method, called multilevel network meta-regression (ML-NMR). The method addresses several limitations with current methods, including synthesizing networks of any size and availability of IPD or aggregate studies, and – crucially for decision-making – producing estimates in any target population of interest.

LEARN MORE

Welcome: Hema Viswanathan, PhD

Precision is excited to welcome Hema Viswanathan as Vice President, PRECISIONheor. With more than 15 years experience in the industry, Hema brings exceptional insights and strategic vision. Hema will support cross functions in health economics and outcomes research (HEOR) from RWE, Evidence Synthesis and Modeling. Welcome to the Precision team!

LEARN MORE